These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 35040901)

  • 21. Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism.
    Haque S; Jawed A; Akhter N; Dar SA; Khan F; Mandal RK; Areeshi MY; Lohani M; Wahid M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9244-9245. PubMed ID: 33015764
    [No Abstract]   [Full Text] [Related]  

  • 22. Acetylsalicylic Acid and COVID-19 Prevention: A Comment.
    Sookaromdee P; Wiwanitkit V
    Clin Appl Thromb Hemost; 2021; 27():10760296211027660. PubMed ID: 34189958
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of preinjury anticoagulants and prescription antiplatelet agents on outcomes in older patients with traumatic brain injury.
    Peck KA; Calvo RY; Schechter MS; Sise CB; Kahl JE; Shackford MC; Shackford SR; Sise MJ; Blaskiewicz DJ
    J Trauma Acute Care Surg; 2014 Feb; 76(2):431-6. PubMed ID: 24458049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
    Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
    JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
    Pancani R; Villari L; Foci V; Parri G; Barsotti F; Patrucco F; Malerba M; Vincenti R; Carrozzi L; Celi A
    Thromb Res; 2021 Jan; 197():44-47. PubMed ID: 33181470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients?
    Mourad JJ; Suhl J
    Anesth Analg; 2021 Sep; 133(3):e41. PubMed ID: 34403399
    [No Abstract]   [Full Text] [Related]  

  • 27. Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs.
    Pannach S; Goetze J; Marten S; Schreier T; Tittl L; Beyer-Westendorf J
    J Gastroenterol; 2017 Dec; 52(12):1211-1220. PubMed ID: 28210867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis.
    Nijman G; Wientjes M; Ramjith J; Janssen N; Hoogerwerf J; Abbink E; Blaauw M; Dofferhoff T; van Apeldoorn M; Veerman K; de Mast Q; Ten Oever J; Hoefsloot W; Reijers MH; van Crevel R; van de Maat JS
    PLoS One; 2021; 16(3):e0249231. PubMed ID: 33770140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage.
    Xian Y; Zhang S; Inohara T; Grau-Sepulveda M; Matsouaka RA; Peterson ED; Piccini JP; Smith EE; Sheth KN; Bhatt DL; Fonarow GC; Schwamm LH
    JAMA Netw Open; 2021 Feb; 4(2):e2037438. PubMed ID: 33591368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous abdominal bleeding associated with SARS-CoV-2 infection: causality or coincidence?
    Sposato B; Croci L; Di Tomassi M; Puttini C; Olivieri C; Alessandri M; Ronchi MC; Donati E; Garcea A; Brazzi A; Migliorini MG; Chigiotti S; Nikiforakis N; Carli T; Canneti E; Strambio F; Cellini C; Nardangeli C; Allegri MP; Bianchi F; Bettini C; Perruzza M; Lanzarone N; Valentini L; Orselli P; Solari M; Cardaci S; Nofri M; Angeli G; Mangani F; Aloia E; Lanari A; Corridi M; Spargi G; Perrella A; Nencioni C
    Acta Biomed; 2021 May; 92(2):e2021199. PubMed ID: 33988163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet Agents and Anticoagulants in Patients with Chronic Kidney Disease - from Pathophysiology to Clinical Practice.
    Lutz J; Jurk K
    Curr Pharm Des; 2017; 23(9):1366-1376. PubMed ID: 27917715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Previous Antithrombotic Therapy, Particularly Anticoagulant, Is Associated with Unfavorable Outcomes in Patients with Primary Spontaneous Intracerebral Hemorrhage Receiving Craniotomy: A Nationwide Population-Based Cohort Study.
    Liu ZH; Chen NY; Tu PH; Yip PK; Wang YC; Chen CC; Chuang CC; Liu CH; Hsu PW; Lin YS
    World Neurosurg; 2019 Aug; 128():e59-e73. PubMed ID: 30954751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
    Roncon L; Zuin M; Rigatelli G
    Intern Emerg Med; 2021 Mar; 16(2):517-518. PubMed ID: 32378044
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of frailty on epistaxis admission, a retrospective cohort study.
    Davies T; Alatsatianos A; Slim MAM; Royce W; Whymark A
    Clin Otolaryngol; 2021 Sep; 46(5):983-990. PubMed ID: 33756072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thrombotic complication of severe COVID-19 pneumonia: stroke due to atypical paradoxical embolism].
    Ballvé-Martín A; Boned S; Rubiera M
    Rev Neurol; 2020 Sep; 71(5):186-190. PubMed ID: 32729110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.
    Sinkovits G; Mező B; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Front Immunol; 2021; 12():663187. PubMed ID: 33841446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland.
    Terlecki M; Wojciechowska W; Klocek M; Olszanecka A; Stolarz-Skrzypek K; Grodzicki T; Małecki M; Katra B; Garlicki A; Bociąga-Jasik M; Sładek K; Matyja A; Wordliczek J; Słowik A; Mach T; Krzanowska K; Krzanowski M; Stręk P; Chłosta P; Hydzik P; Korkosz M; Popiela T; Pilecki M; Gądek A; Rajzer M
    Kardiol Pol; 2021; 79(7-8):773-780. PubMed ID: 33926173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients.
    Parker K; Hamilton P; Hanumapura P; Castelino L; Murphy M; Challiner R; Thachil J; Ebah L
    BMC Nephrol; 2021 Jun; 22(1):224. PubMed ID: 34134645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 and thrombosis: Clinical features, mechanism of disease, and therapeutic implications.
    Violi F; Pignatelli P; Cammisotto V; Carnevale R; Nocella C
    Kardiol Pol; 2021; 79(11):1197-1205. PubMed ID: 34847237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.